Bruce & Co., Inc.
Bruce & Co., Inc. reported 41 holdings worth US$369M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Bruce & Co., Inc. reported 41 holdings worth US$369M as of Sep 30, 2026. Largest: AbbVie Inc., Allstate Corporation (the) and U-Haul Holding Company. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 41
- Value as reported
- US$369M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| AbbVie Inc. | 121K | US$31.7M | 8.6% |
| Allstate Corporation (the) | 123K | US$27.2M | 7.4% |
| U-Haul Holding Company | 460K | US$24.8M | 6.7% |
| Duke Energy Corporation (Holding Company) | 145K | US$16.5M | 4.5% |
| Vicor Corporation | 48,000 | US$13.9M | 3.8% |
| Xcel Energy Inc. | 183K | US$12.9M | 3.5% |
| AT&T Inc. | 518K | US$12.6M | 3.4% |
| Beta Bionics, Inc. | 666K | US$12.6M | 3.4% |
| Kodiak Sciences Inc | 130K | US$12.3M | 3.3% |
| Apple Inc | 36,900 | US$12.3M | 3.3% |
| Newmont Corporation | 100K | US$11.6M | 3.2% |
| Abbott Laboratories | 112K | US$11.1M | 3.0% |
| Insteel Industries, Inc. | 343K | US$10M | 2.7% |
| CMS Energy Corporation | 153K | US$9.65M | 2.6% |
| Supernus Pharmaceuticals, Inc. | 200K | US$8.61M | 2.3% |
| Archer-Daniels-Midland Company | 100K | US$7.94M | 2.2% |
| Pfizer, Inc. | 268K | US$7.65M | 2.1% |
| Avista Corporation | 200K | US$7.02M | 1.9% |
| Darling Ingredients Inc. | 105K | US$6.37M | 1.7% |
| Chemours Company (the) | 250K | US$3.39M | 0.92% |
| Personalis, Inc. | 200K | US$3.26M | 0.88% |
| Fate Therapeutics, Inc. | 989K | US$2.34M | 0.64% |
| Eli Lilly and Company | 2,000 | US$2.31M | 0.63% |
| RLI Corp. | 39,000 | US$2.16M | 0.58% |
| Edap Tms SA | 439K | US$1.96M | 0.53% |
| Apogee Enterprises, Inc. | 50,000 | US$1.77M | 0.48% |
| Venture Global, Inc. | 100K | US$1.26M | 0.34% |
| Viatris Inc. | 57,696 | US$1.02M | 0.28% |
| 908 Devices Inc. | 68,286 | US$843K | 0.23% |
| MannKind Corporation | 195K | US$761K | 0.21% |
| Valeant Pharmaceuticals International Inc | 114K | US$665K | 0.18% |
| WEC Energy Group, Inc. | 3,945 | US$398K | 0.11% |
| Caribou Biosciences, Inc. | 250K | US$318K | 0.09% |
Source
Download original · View original at SEC
Related